Deal Library / Pharma BD Deal Intelligence

Servier — Pharma Deals

The Pharma Closeout tracks 3 deals, $5.5B in disclosed deal value, 2 with a post-close Outcome Score for Servier.

Median Critic Score: 70  ·  Median Outcome Score: 82

Best outcome: Servier / Shire plc (Oncology Business) (88)  ·  Weakest outcome: Servier / Edgewise Therapeutics, Inc. (75)

All 3 deals

• Servier / Shire plc (Oncology Business) — 2018 · $2.4B · Worked — the deal delivered on its rationale.
• Servier / Edgewise Therapeutics, Inc. — 2026 · $2.6B · Worked — the deal delivered on its rationale.
• Servier / Kaerus Bioscience Ltd. — 2025 · $450M

← Deal Library  ·  Interactive search  ·  How we score deals